THYROCARE Thyrocare Technologies Ltd Earnings Calls Announcement 2026 - Earnings Conference Call Thyrocare’s Jan 28 earnings call transcript shows 18% quarterly growth (pathology ~20%, radiology softer), 29.5% EBITDA margins, and mid-teens long-term growth guidance, with details on franchise pricing and margin impact..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Thyrocare Technologies Ltd